Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study

Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study

Data regarding protection against mortality and severe complications after Omicron BA.2 infection with CoronaVac and BNT162b2 vaccines remains limited. We conducted a case–control study to evaluate the risk of severe complications and mortality following 1–3 doses of CoronaVac and BNT162b2 using ele...

Full description

Bibliographic Details
Main Authors: Vincent Ka Chun Yan, Eric Yuk Fai Wan, Xuxiao Ye, Anna Hoi Ying Mok, Francisco Tsz Tsun Lai, Celine Sze Ling Chui, Xue Li, Carlos King Ho Wong, Philip Hei Li, Tiantian Ma, Simon Qin, Vincent Kai Chung Wong, Tat Chi Tsang, Sik Hon Tsui, William Chun Ming Chui, Benjamin John Cowling, Gabriel Matthew Leung, Chak Sing Lau, Ian Chi Kei Wong, Esther Wai Yin Chan
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Emerging Microbes and Infections
Subjects:
COVID-19
Vaccine effectiveness
Omicron BA.2
CoronaVac
BNT162b2
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2022.2114854

Internet

https://www.tandfonline.com/doi/10.1080/22221751.2022.2114854

Similar Items